- 1
- 0
- 约2千字
- 约 138页
- 2025-10-21 发布于广东
- 举报
降糖药物;糖尿病药物治疗需面对的问题;PowerPointPres;九大类降糖药物;双胍类药物;双胍类药物;PowerPointPres;二甲双胍剂量-疗效依赖性研究;双胍类药物注意;PowerPointPres;磺脲类;磺脲类降糖药物的种类、特点;磺脲类药物作用机理;磺脲类药物的副作用;磺脲类药物临床应用的注意点;什么是磺脲类药物失效?;格列奈类;格列奈类的种类;格列奈类的作用机制及特点;格列奈类临床应用注意点;胰岛素增敏剂-噻唑烷二酮类t;噻唑烷二酮类的作用机理;噻唑烷二酮类药物的临床应用;α-葡萄糖苷酶抑制剂;α-葡萄糖苷酶抑制剂的作用机理;α-葡萄糖苷酶抑制剂的临床应用;胰高糖素样多肽1(GLP-1);GLP-1是由肠道L细胞分泌的;GLP-1受体激动剂对人体具有;胰高糖素样多肽1(GLP-1);胰高糖素样多肽1(GLP-1);DDP-4抑制剂;常用列汀类药物比较;DDP-4抑制剂的作用机制;DDP-4抑制剂的临床应用;DPP-4抑制剂与GLP-1类;SGLT2抑制剂;PowerPointPres;肾脏在葡萄糖稳态平衡中起到了重;正常人葡萄糖在肾脏滤过和重吸收;PowerPointPres;PowerPointPres;PowerPointPres;胰岛素;条件;PowerPointPres;胰岛素的起始治疗中基础胰岛素的;预混胰岛素的使用;多次胰岛素注射治疗(胰岛素;特殊情况下胰岛素的应用;PowerPointPres;降糖药物的选择;2020年2型糖尿病基层用药指;中国2型糖尿病防治指南;PowerPointPres;降糖药物对糖化血红蛋白的作用;更强调血糖控制目标应个体化;更强调血糖控制目标应个体化;关键点;小结;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres;PowerPointPres
原创力文档

文档评论(0)